TSS
TEVA icon

Two Sigma Securities’s Teva Pharmaceuticals TEVA Stock Holding History

Two Sigma Securities’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-26,200
Closed -$472K – 3130
2024
Q3 		$472K Sell
26,200
-98,500
-79% -$1.72M 0.01% 1370
2024
Q2 		$2.03M Sell
124,700
-137,300
-52% -$2.11M 0.02% 709
2024
Q1 		$3.7M Buy
262,000
+221,600
+549% +$2.79M 0.04% 495
2023
Q4 		$422K Buy
+40,400
New +$377K ﹤0.01% 1681
2023
Q1 		– Sell
-64,200
Closed -$586K – 3258
2022
Q4 		$586K Buy
64,200
+54,000
+529% +$471K 0.02% 981
2022
Q3 		$82K Buy
+10,200
New +$90.2K ﹤0.01% 2123
2022
Q1 		– Sell
-16,700
Closed -$134K – 2501
2021
Q4 		$134K Buy
+16,700
New +$151K 0.01% 1138
2021
Q3 		– Sell
-11,300
Closed -$112K – 1955
2021
Q2 		$112K Buy
11,300
+100
+0.9% +$1.06K ﹤0.01% 1351
2021
Q1 		$129K Sell
11,200
-13,700
-55% -$157K 0.01% 679
2020
Q4 		$240K Buy
24,900
+9,700
+64% +$92.9K 0.01% 1235
2020
Q3 		$137K Buy
+15,200
New +$161K ﹤0.01% 1159
2020
Q2 		– Sell
-47,500
Closed -$427K – 1732
2020
Q1 		$427K Buy
+47,500
New +$487K 0.01% 688
2019
Q3 		– Sell
-41,500
Closed -$383K – 2452
2019
Q2 		$383K Sell
41,500
-104,600
-72% -$1.26M ﹤0.01% 1299
2019
Q1 		$2.29M Buy
146,100
+86,300
+144% +$1.52M 0.02% 298
2018
Q4 		$922K Sell
59,800
-110,700
-65% -$2.27M 0.01% 673
2018
Q3 		$3.67M Sell
170,500
-181,600
-52% -$4.22M 0.02% 477
2018
Q2 		$8.56M Buy
352,100
+12,400
+4% +$253K 0.04% 320
2018
Q1 		$5.8M Buy
339,700
+286,600
+540% +$5.6M 0.03% 431
2017
Q4 		$1.01M Buy
+53,100
New +$799K 0.03% 421

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Two Sigma Securities's TEVA Position: Q2 2026 in Review

Two Sigma Securities opened a new position in Teva Pharmaceuticals (TEVA) in Q2 2026: 6,797 shares worth $230K. The stake represents 0.02% of the portfolio and ranks #1073 among its holdings. This is a return to the name: Two Sigma Securities previously reported a position in TEVA as recently as Q2 2024.

Two Sigma Securities first reported a position in TEVA in Q1 2016 and has held it in 26 quarters since. The position peaked at $2.54M in Q3 2016. 675 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Two Sigma Securities held 6,797 shares of Teva Pharmaceuticals worth $230K as of Q2 2026.
  • Teva Pharmaceuticals was a new Two Sigma Securities position in Q2 2026.
  • Teva Pharmaceuticals made up 0.02% of Two Sigma Securities's portfolio in Q2 2026, its #1073 holding.
  • Two Sigma Securities first reported a position in Teva Pharmaceuticals in Q1 2016 and has held it in 26 quarters since.
  • Two Sigma Securities's Teva Pharmaceuticals position peaked at $2.54M in Q3 2016.
  • 675 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Two Sigma Securities's 13F filing for Q2 2026, filed 14 Aug 2026.